An MDA fundraiser event for ALS research, the Atlanta Night of Hope Gala will this year showcase ALS patient April Byars and ...

Columnist Juliet Taylor doesn't remember taking the photo — a snapshot in time of her late husband, Jeff — but she remembers ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Fifteen U.S. nonprofit organizations formed a new ALS group, ALS United, to help address the needs of people living with ALS.

Neighborhood disadvantage, or living in a poorer region, was linked to significantly shorter survival time for ALS patients ...

Getting a cold or the flu can have severe consequences for columnist Kristin Neva's husband, who is living with ALS.

Neuropeutics is collaborating with LifeArc on a small molecule therapy that reportedly lowered TDP-43 clumping in an animal ...

Repeated brain injury resulted in SOD1-ALS mice showing greater weight loss, an earlier tremor in the hind limbs, and ...

A mishap with her ankle-foot orthoses was discouraging, but columnist Dagmar Munn quickly happened upon the "mini-miracles" that followed.

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

In a real-world study, In the end, researchers compared 395 ALS patients who'd been given Radicava against 395 matched controls who hadn't.